The haze of financial crisis and the total import and export of traditional Chinese medicine exceeded 2 billion US dollars

Affected by the global financial crisis, China's foreign trade suffered a severe cold in 2009, with the total import and export volume down 13.9% year-on-year The pharmaceutical industry experienced a tough journey in 2008 and the first half of 2009, and the import and export situation in the second half of the year picked up rapidly, which was in contrast to the overall foreign trade situation of China, with the total import and export volume up 9.8% year-on-year The trade of traditional Chinese medicine products is turning around The total amount of import and export has exceeded 2 billion US dollars The year-on-year growth rate ranks first in all kinds of medicine products (Western medicine, medical equipment, traditional Chinese Medicine), with a growth rate of 14.36%, the best level since 2007 Among them, the export of traditional Chinese medicine products reached US $1.46 billion, a year-on-year increase of 11.72%, 3 percentage points higher than that in 2008; the import of traditional Chinese medicine products reached US $540 million, a year-on-year increase of 22.14%, 1.6 percentage points higher than that in 2008, reaching the highest point in the past six years Trade overview 1 The trade situation of all kinds of traditional Chinese medicine commodities is different In 2009, the foreign trade of traditional Chinese medicine commodities continued to maintain a surplus, with the surplus reaching US $920 million, but the export growth rate was 10 percentage points lower than the import growth rate In each single commodity, the trade of extract and traditional Chinese medicine is in surplus, and the export of extract accounts for 44.8% of the total export of traditional Chinese medicine products, ranking first; the export of Chinese medicine Pieces accounts for 37.92% of the total export of traditional Chinese medicine products, ranking second; the trade of traditional Chinese medicine and health care products is in deficit, and the trade of traditional Chinese medicine is in deficit for the second time after 2008, with the deficit slightly increasing; the trade of health care products is in deficit Except for 2006, it has been in deficit since 2003 In 2009, the reverse balance reached 23.145 million US dollars, the highest year of the reverse balance 2 General trade is the main mode of import and export of traditional Chinese medicine In terms of trade mode, general trade is still the main mode of import and export of traditional Chinese medicine Among them, the products of traditional Chinese medicine exported by general trade mode account for 83.73% of the total export of traditional Chinese medicine; the products of traditional Chinese medicine imported by general trade mode account for 68.97% of the total import of traditional Chinese medicine In the import trade, 17.14% of the import trade and 7.89% of the export trade, respectively The warehousing and entrepot trade of goods in the bonded area is another characteristic way of importing traditional Chinese medicine In 2009, the volume of imported traditional Chinese medicine goods in this way reached 21754 tons Border small trade is another characteristic of traditional Chinese medicine export In 2009, the export volume of traditional Chinese medicine commodities reached 31875 tons, which is the most export mode except general trade 3 The enterprise structure shows a trend of diversification In 2009, there are 2766 export enterprises of traditional Chinese medicine products Private enterprises have become the main export force, accounting for 41.14% of the total export amount; foreign-funded enterprises account for 33.78% of the total export amount; state-owned enterprises have withdrawn from the first export group of traditional Chinese medicine products, accounting for only 24.87% of the total export amount It is worth noting that among the private enterprises, the export volume of private enterprises accounts for more than 90% There are 1380 enterprises engaged in the import of traditional Chinese medicine products The import momentum of foreign-funded enterprises is strong The import amount is as high as 270 million US dollars, accounting for 49.73% Among them, the wholly foreign-owned enterprises are the main force among the foreign-funded enterprises, the import amount is as high as 190 million US dollars; the import amount of private enterprises is 210 million US dollars, accounting for 39.07%; the import amount of state-owned enterprises is only 60 million US dollars, accounting for 11.18% In 2009, the import and export trade characteristics of various categories of traditional Chinese medicine products: 1 Chinese herbal medicine Pieces: two days at the end of the year In 2009, the import and export performance of Chinese herbal medicine was outstanding The import and export volume reached 650 million US dollars, an increase of 7.2% year on year Among them, the export volume was US $550 million, up 6.4% year on year; the import volume was US $90 million, up 12.2% year on year, basically maintaining a stable growth But in the first half and the second half of the year, the export situation is obviously different In the first half and the second half of the year, there is a pattern of "ice and fire" In the first half of the year, the export volume was obviously weak, with a year-on-year decrease of 30% in January; in the second half of the year, the export volume began to rebound strongly, with a year-on-year increase of 30% in December Two completely opposite situations at the beginning of the year and the end of the year reflected the recovery of the export volume of Chinese herbal medicine Pieces in the past year, especially in the second half of 2009 In 2009, the export volume of Chinese herbal medicines and pieces of Chinese herbal medicines has a large increase year on year The export volume of wolfberry, Cordyceps sinensis, chrysanthemum and Atractylodes macrocephala increased by more than 50% The biggest increase was cumin, with export volume and export volume increasing by more than 300% The main export market of Chinese herbal medicines in China is Asia Among them, Hong Kong, Japan and Vietnam are the main three regions, and the total exports of the three regions account for more than half of the total exports Some of the Chinese herbal medicines exported to Hong Kong are processed into Chinese patent medicines, and most of them are exported to other countries and regions in the form of herbal medicines, such as the United States, Taiwan Province and Japan Most of the major export provinces of Chinese Herbal Pieces in China have clear export positioning Guangdong and Guangxi, the two provinces with the largest export volume, have been in the top two in terms of their location advantages in recent years Guangdong Province is the main export market of Chinese herbal medicine pieces due to its proximity to Hong Kong, China, Taiwan and Southeast Asia; Guangxi is close to Vietnam, with a unique geographical location, and most of the Chinese herbal medicine pieces are exported to Vietnam through border trade; Bozhou, Anhui Province, for the Korean Chinese herbal medicine Pieces Market, saw the largest export growth in 2009, with a year-on-year increase of 45% In 2009, there were 1000 enterprises exporting Chinese herbal medicine and decoction pieces in China, and only 7 enterprises with an export volume of more than US $10 million The top five export enterprises are Guangxi Ningming import and Export Trade Corporation, China Pharmaceutical and Health Products Co., Ltd., Shenzhen Jincun Pharmaceutical Co., Ltd., Bozhou boguang decoction pieces Co., Ltd and Sichuan Chuancun traditional Chinese Medicine Co., Ltd 2 Extract: the strong growth has become the main driving force for the export of traditional Chinese medicine In 2009, China's plant extract was the most prominent commodity category in the import and export of traditional Chinese medicine, with the import and export volume reaching US $820 million, an increase of 36.1% year on year Among them, the export reached US $660 million, an increase of 23.7% year on year; the import reached US $160 million, an increase of 129.2% year on year The export volume accounts for 44.8% of the total export volume of traditional Chinese medicine, which is the driving force to promote the export of traditional Chinese medicine In 2009, the monthly export of plant extracts was basically stable, and the export volume remained above or below US $50 million In the first half of the year, exports showed a slight decline In the second half of the year, exports showed a rapid growth in most months, and the year-on-year growth in September was close to 100% From the perspective of export product structure, the largest increase in export amount is natural pigment products From the single variety analysis, the export amount of Stevia extract increased significantly In 2009, the export amount of Stevia extract reached 84.3 million US dollars, an increase of 132% year on year Plant extract industry has a certain cluster effect, and the plant extract industry in each province has its own characteristics For example, Shandong Province mainly produces plant extracts for food additives, while Zhejiang and Shanghai mainly produce plant extracts for medicinal and health products According to statistics, in 2009, the export volume of the main export food additives and fragrances and plant extracts increased significantly For example, Shandong and Jiangxi, the export of Stevia extract increased greatly, and the export of Yunnan flavor and fragrance increased significantly Provinces and cities that export plant extracts for medicinal and health products, such as Zhejiang and Beijing, saw a slight decline in export volume In 2009, the main export markets of plant extracts in China are still Japan and the United States The Japanese market is relatively stable, and the price and export volume of plant extracts maintain a steady increase Most of the plant extracts imported from Japan are made by Japanese Chinese medicine enterprises investing in Chinese enterprises to complete the preliminary extraction production of medicinal materials, such as Japan Tsumura and other enterprises The export volume of plant extracts to the U.S market increased significantly year on year, mainly because the price of extracts exported to the U.S increased significantly, with an average increase of 49.5% The export market of other plant extracts is the most eye-catching in India and Malaysia, with a year-on-year growth of more than 100% These two markets are similar to the Mexican market, which performed prominently last year They are both driven by the sharp increase of single commodity exports Most of the commodities exported to India are concentrated in natural plant extracts, such as natural pigments, flavors and fragrances More than 90% of the commodities exported to Malaysia are Stevia extract, which are widely used in food industry 3 Chinese patent medicine: import and export shrank at the same time, and the trade deficit continued in 2009 The cumulative import and export volume of Chinese patent medicine reached 339 million US dollars, down 4% year on year Among them, the export value was US $160 million, down 4.23% year on year; the import value was US $176 million, down 3.88% year on year In 2009, the trade deficit of Chinese patent medicine was 12.42 million US dollars, basically equivalent to the deficit of 12.28 million US dollars last year In 2009, China exported Chinese patent medicines to 95 countries and regions, among which South Korea, Benin and Vietnam accounted for the largest export growth; Indonesia, Ghana, the United Arab Emirates, Canada and the United Kingdom accounted for the largest export decline The main export areas of Chinese patent medicine in China are still Hong Kong, Japan and the United States, which account for about 57% of the export of Chinese patent medicine in China Hong Kong is the largest export region of Chinese patent medicine in China, accounting for 41% of China's export of Chinese patent medicine In 2009, China's export of Chinese patent medicine to the region reached US $67.34 million, an increase of about 6% year on year There are two main reasons: first, there is a strong demand for Chinese patent medicines in Hong Kong; second, some Hong Kong merchants have branches in the United States, Europe and other countries, and Hong Kong has become a transit station for the export of Chinese patent medicines to the world In 2009, China's export volume of "Chinese patent medicine" to Japan decreased by 22% year on year, and the export amount was 14.62 million US dollars, down 9.5% year on year In addition, at the end of 2009, the Japanese government's budget screening working group plans to exclude Chinese medicine from the application of public health insurance If this plan is implemented, it means that Japanese traditional medicine, which has been used as medical insurance medicine since 1976, may become self funded medicine in Japan, which will have a certain impact on the export of Chinese patent medicine to Japan in the future, which deserves our long-term attention In 2009, China's export volume of "Chinese patent medicine" to the European Union dropped by 19% year on year, and the export amount was US $10.26 million, down 18% year on year The transition period of EU's "traditional botanical medicine registration procedure directive" will come to an end Up to now, no Chinese patent medicine has passed the EU's simple registration in China, which means that since April 2011, the sales of Chinese traditional medicine in the EU will be strictly managed, which will have a great impact on the future export of Chinese traditional medicine to the EU market In 2009, there were 661 Chinese patent medicine export enterprises, 8% less than the same period last year State owned enterprises are still the main part of the export of Chinese patent medicine, with the annual export reaching 95.88 million US dollars, accounting for 59% of the total export of Chinese patent medicine, down 0.5% compared with the same period last year Because state-owned Chinese patent medicine enterprises and their products have high brand reputation, large production scale, independent product intellectual property rights and relatively fixed market consumers, the export of state-owned Chinese patent medicine enterprises has been relatively stable The top three Chinese patent medicine export enterprises are Beijing Tongrentang Co., Ltd., Zhangzhou Pianzihuang Pharmaceutical Co., Ltd and Guangzhou Pharmaceutical Import and export company 4 Health care products: not warm and not hot According to the statistics of customs, the cumulative import and export volume of health care products in China reached 200 million US dollars in 2009, up 3.1% year on year Among them, the export volume reached US $89.1 million, a year-on-year increase of 2.2%; the import volume reached US $110 million, a year-on-year increase